In today’s rapidly changing environment, organizations face challenges, such as financial constraints, the emergence of non-traditional competitors, the need for internal transformation, and many others. However, we are optimistic that we can continue to create innovative solutions with high market value! This event presents a crucial opportunity to address these challenges head-on, improve the company’s performance, and quickly bring creative solutions to patients and customers. We will learn together with innovation experts, transformation and business leaders, decision-makers, and life science entrepreneurs to share valuable insights and experiences. By focusing on sharpening innovation culture, building capabilities for business growth, agile transformation, fundraising, and digitalization, this event is a powerful platform for learning and networking, connecting you with like-minded professionals. You will get robust solutions to implement immediately, developed for your specific situation so that you can meet your ambitions and aspirations!
Transformation
Series #2
Journey for Accelerating Sustainable Company Performance In a Fast-Changing Market
- Lyon | November 28, 2024 | 09:00 - 20:00
Organized by
Oréda Boussadia, Ph.D., MBA
Kasia Hein-Peters, M.D.
Please get in touch with us with any questions. Our contact details are in the bios.
Amel Zahui
Event Manager
Student at SKEMA Business School
objectives
1
Solve your most
pressing business
growth challenges.
2
Obtain actionable insights specific to your company.
3
Transform into an agile, innovative organization through digitalization, mindset, culture, capabilities, and process.
Before the Event
You will receive your link to fill out the InnoSurvey® and assess your organization’s innovation capabilities. Your free, detailed, individualized report with benchmarks, analyses, and recommendations will await you in Lyon. During the event, you will have the opportunity to compare your findings with those of other participants. Also, you will receive another link to the PESTLED360 page to fill in market trends that impact your company.
Agenda
Interactive & Dynamic
| Time | Topic |
|---|---|
| 09:00 - 10:00 | Coffee & Networking |
| 10:00 - 10:15 |
Welcome to the Journey Kasia Hein-Peters, MD, Founder at Abante Scientific, and Oréda Boussadia, PhD, MBA, Partner, Marketing & Business Excellence |
| 10:15 - 10:30 |
LifeHub Lyon: Open Innovation and Dialogue Philippe Méresse, PhD, LifeHub Bayer, Lyon |
| 10:30 - 11:15 |
Foundation of Sustainable Growth Through Innovation Kasia Hein-Peters, MD, Founder at Abante Scientific |
| 11:15 - 12:00 |
Macro Drivers Analysis Using Advanced Pestled Tool (Workshop) Facilitated by Kasia Hein-Peters, MD, Founder at Abante Scientific and Oréda Boussadia, PhD, MBA, Partner, Marketing & Business Excellence |
| 12:00 – 13:30 |
Lunch & Networking 30-min Visit to Bayer Research Center (limit 25 participants, registration required) |
| 13:30 - 14:15 |
Transformation to Agile Marketing & Business Organization to Shape the Future Oréda Boussadia, PhD, MBA, Partner, Marketing & Business Excellence |
| 14:15 - 15:00 |
Innovate, Fund, Thrive. The Entrepreneur Journey to VC Fundraising Philippe Tramoy, VC Fund Partner & Co-Author |
| 15:00 - 15:45 |
Collaborative AI in the Digitization of R&D and Data Management as an Innovation Driver Djomangan Adama Ouattara, PhD, CEO & Co-Founder at Gencovery |
| 15:45 - 16:30 |
Coffee Break & Networking Book Purchase and Signing by Philippe Tramoy |
| 16:30 - 17:00 |
Driving Sustainable Innovation Through a Diversity-Focused Mindset Catherine Sirven, Digital Transformation Lead at Bayer |
| 17:00 - 18:00 |
Innovation Capabilities - InnoSurvey Results (Workshop) Facilitated Kasia Hein-Peters, MD, Founder at Abante Scientific, and Oréda Boussadia, PhD, MBA, Partner, Marketing & Business Excellence |
| 18:00 - 18:45 |
Speaker Panel and Q&A Session Joined by Fabrice Romano and Dr. Pierre Morgon |
| 18:45 - 20:00 | Apéro Dinatoire & Networking |
After The Event
You will be able to immediately implement your specific recommendations from InnoSurvey®, as well as actionable ideas generated during presentations and discussions with peers.
Within two weeks, you will receive a Comprehensive Report on Key Drivers and the Changing Environment for Innovation in the Global Healthcare & Life Science Industries, based on previous and current PESTLED360 sessions with industry leaders, developed especially for event participants.
Oréda Boussadia, Ph.D., MBA
SPEAKER & ORGANIZER
Corporate visionary and executive leader in marketing and business with two decades of experience in global biotech and health tech companies, which provide access to technological platforms to support drug developers in accelerating their innovations.
Oréda partners with companies such as Charles River, Taconic, Eurofins, Concept Life Science, Batavia Biosciences, Epivax, and many startups that need to strengthen the management of the company’s growth and performance. Since 2012, she has decided to support companies by being a business angel at Angelor, Lyon, France. For many years, Oréda has been an external marketing and business expert at the CNRS Innovation and the European Innovation Council, supporting company creation and start-ups as an advisor and mentor.
She obtained an executive Design Thinking and Agile Methods certificate at the ESSEC Business School and an Executive MBA at IFG Education. Before joining the industry in 2001, she spent ten years as a researcher at the Max-Planck-Institute für Immunbiologie und Epigenitik in Freiburg, Germany, and Gustave Roussy Institute in Paris, France, where she defended her Ph.D.
Kasia Hein-Peters, M.D.
SPEAKER & ORGANIZER
After 25+ years of leadership roles in Fortune 500 companies (Eli Lilly, Merck (MSD), Novartis, Sanofi, and Terumo), Kasia now helps healthcare, life science, and digital health organizations de-risk launching new products, reach strategic goals, achieve sustainable growth, create leading brands, and scale up their organizations by developing innovation capabilities and applying a systematic innovation management process. She increases the odds of successfully bringing life science innovations to the market, aiming to improve patient outcomes, social impact, and organizations’ performance. In addition to her advisory, co-founder, and fractional executive roles at startup companies, Kasia is deeply committed to fostering innovation. She serves as a mentor in incubators and accelerators, sharing her expertise and guiding the next generation of healthcare innovators.
Kasia graduated as a medical doctor and completed her residency in psychiatry at the Medical University in Wroclaw, Poland. She founded Abante Scientific (www.abantescientific.com), is board-certified in AI in Medicine, and has been an Innovation 360 Licensed Practitioner since 2023.
Djomangan Adama Ouattara, Ph.D.
SPEAKER
Djomangan Adama OUATTARA is CEO and cofounder of Gencovery (Lyon, France), which ambitions to revolutionize R&D and productivity in digital life sciences. Adama holds a PhD in Electrical engineering from Ecole Centrale de Nantes (France).
Over the last 15 years, he worked as computational scientist and leader in several organizations (e.g.: Université Libre de Bruxelles in Belgium, CNRS in France, The Bio-Intelligence program led by Dassault Systèmes in France). Its core expertise encompasses software engineering, artificial intelligence and in silico modeling of complex biological systems (systems oncology, toxicology, bioartificial organs, systems metabolomics, digital twin of cellular metabolism).
After leading the bioinformatics group in the Technology Research Institute BIOASTER at Lyon (France), Adama cofounded Gencovery in 2020 with a purpose to disrupt digital life sciences. Gencovery is developing and providing Constellab™, a leading digital infrastructure to get rid of data silos by hyper-connecting, consolidating data to unlock its full potential at all stages of their value chains of companies and organizations.
Philippe Tramoy
SPEAKER
Philippe has been working in life sciences with wide-ranging responsibilities for over 25 years. He started research on a gene linked to leukemia and programmed cell death (apoptosis). He worked four years for a U.S.-based contract manufacturing organization (CMO), acquired by Rhodia (now Solvay), as a Business Development Manager for the EMEA region. Later, he founded and managed a market and business intelligence company with offices in France, Switzerland and Israel. He is a Partner for a Deep Tech fund at one of the European leaders in venture capital, financing start-up companies in the field of digital technologies and life sciences linked to academic and university institutions in France such as Sorbonne University, University of Paris IV, National Museum of Natural History, IRCAM, ENSCI, CNRS and Curie Institute. He is also a board member of life science companies such as Pep-Therapy, CryoCapCell, Scipio Biosciences, and Aenitis Technologies.
Philippe has a Master’s in Biochemistry (University of Burgundy), a Master’s in Immunology and Molecular Biology (Ecole Normale Supérieure Lyon), a Master’s in Finance (IAE Paris-Sorbonne) and a Master’s in Marketing (HEC Paris). He has authored articles for various publications and is the author of market research reports on topics such as the microalgae market, the European contract biomanufacturing market, cancer cytostatic compounds, Alzheimer’s disease and private equity “the business of building business”.
Philippe is a co-author of the book “Innovate, Fund, Thrive—The EntrepEntrepreneur’s Playbook to VC Fundraising in Life Sciences,” which was published in 2024 by Routledge Taylor and Francis Group and can be found here:
Catherine Sirven
SPEAKER
Catherine Sirven is a leader in digital transformation and an advocate for open and digital innovation within the agricultural sector. With a background in molecular biology, Catherine has led projects and teams in plant health research, specializing in bioinformatics and plant biotechnology. Her pivotal role in initiating research projects to identify the activities and mode of action of molecules, bacterial extracts, peptides, and small RNAs against plant diseases has been widely recognized.
As a molecular biologist, Catherine has contributed significantly to the field, including the publication of articles on topics such as fungicide resistance and soybean rust genome sequencing. She also serves as the vice president of the Elixir industrial advisory committee for European bioinformatics and has actively participated in and moderated conferences focused on open innovation in the agritech sector.
Catherine is renowned for her commitment to promoting sustainable innovation through a diversity mindset. Her unique approach seamlessly integrates advanced digital strategies with a deep appreciation for diverse viewpoints, reflecting her belief that true innovation thrives when a multitude of perspectives are embraced. Her leadership, vision, and dedication to digital transformation and innovation have played a key role in fostering the emergence of “augmented scientists” who incorporate artificial intelligence into their research processes in chemistry and biology.
Philippe Méresse, Ph.D.
SPEAKER
Trained as an engineer and doctor in organic chemistry, I held several positions in the La Dargoire research center in chemistry functions or supporting the activities of researchers (structural analysis, robotics, logistics, IT, etc.). After a stint at headquarters, particularly in HR project management functions, I returned to the research center to implement the LifeHub Lyon, for which I am today responsible, particularly for its dialogue activity around agriculture and crop protection.
Fabrice Romano
PANELIST
Fabrice Romano has been a serial entrepreneur in the field of innovative medical technologies for 35 years. He has created several companies, including Eye Tech Care in 2008 and Keranova in 2015. The latter two have raised around €60 million, created around a hundred jobs, and brought to market sophisticated and highly innovative medical devices for the treatment of certain eye diseases, such as the ultra-fast robotic FemtoMatrix laser for cataract surgery.
Pierre A. Morgon
PANELIST
Pierre A. MORGON is CEO of MRGN Advisors, Chief Business Officer at Nuvamid, Co-Founder and interim CEO at Ibex Therapeutics, Co-Founder and Director at Anemos Therapeutics, Interim General Manager at Molsid and Regional Partner for Switzerland at Merieux Equity Partners. He is Chairman of the Boards of Kupando, Limula and Health Technologies Holding, as well as Non-Executive Director to the Boards of Barinthus Bio, Univercells, Zambon Biotech, Lys Therapeutics, IABS (International Alliance for Biological Standardization) and GCRI (The Global Centre for Risk and Innovation).
Pierre has over 35 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies.
He is a lecturer in several MBA programs and in life science conferences, and at the Mass Challenge incubator in Switzerland where he is a mentor for start-up life sciences companies.
He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA, and he is an alumnus of INSEAD and IMD.
€485 per person
Included in the price are:
- InnoSurvey® Customized Report specific for your company
- The comprehensive market report on Market Forces and Changing Environment in Global Healthcare & Life Sciences with proposed innovative solutions
We are delighted that Bayer will welcome us to its LifeHub in Lyon, the center of open innovation and collaboration.
- Research Center De La Dargoire—Bayer, 14 Imp. Pierre Baizet, 69009 Lyon, France
- Several public transportation options are available.
- Parking will be accessible inside Bayer's location.
After registering for the event, you will receive another link to book the Bayer’s Research Center Tour. The space is limited – only the first 25 participants will be accepted.
Oréda offers one of her paintings, as a reward to one person among those who donate any amount to Fondation pour la Recherche Médicale (FRM), to support medical research.
- Rondeur du Monde #48
- Acrylic 60×80 cm
To see other Oréda paintings, connect with her on Instagram.
